Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG-guided vs conventional ELND in prostate cancer
NCT04882618Phase 4Unknown
- Sponsor
- Erciyes University
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in prostate cancer (PCa), lymph node metastasis, sponsored by Erciyes University. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
prostate cancer (PCa)lymph node metastasis
Beyond the preview
Go deeper on NCT04882618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882618.